![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/twitter.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/Logo_LinkedIn_round.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/youtube.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/flickr.png)
Today, organisations representing the life science industry in the EU […]
READ MOREThe associations representing the European and British life science industry […]
READ MOREThe 1st Value Added Medicines conference organised by the Value […]
READ MOREMedicines for Europe is very glad to see the Council […]
READ MOREThe newly elected President of Medicines for Europe – Marc-Alexander Mahl – […]
READ MOREValue added medicines represent a major opportunity to improve patients’ […]
READ MOREA new study “Value Added Medicines: Time to Adjust the […]
Read moreBiosimilar medicines are transforming treatment by enabling better access to […]
Read moreOver 100 participants explored different ways and opportunities to ensure […]
Read moreA special satellite symposium was organized on “Value added medicines […]
Read more